And Mycobacterium Gordonae by High-Performance Liquid Chromatography of Their Mycolic Acids W
Total Page:16
File Type:pdf, Size:1020Kb
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1988, p. 50-53 Vol. 26, No. 1 0095-1137/88/010050-04$02.00/0 Copyright © 1988, American Society for Microbiology Identification of Major Slowly Growing Pathogenic Mycobacteria and Mycobacterium gordonae by High-Performance Liquid Chromatography of Their Mycolic Acids W. RAY BUTLER* AND JAMES 0. KILBURN Mycobacteriology Laboratory, Respiratory Diseases Branch, Division of Bacterial Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 30333 Received 15 June 1987/Accepted 9 October 1987 A rapid, reverse-phase high-performance liquid chromatography method was used to detect p-bromophe- nacyl mycolic acid ester patterns for strains of four major pathogenic Mycobacteriunt species and for the most commonly encountered saprophytic species, Mycobacterium gordonae. Mycobacteria in low numbers (2.5 x 106 CFU) were detected and identified to the species level. Standard chromatographic patterns characteristic of each species were established. Simple pattern recognition enabled rapid identification of M. tuberculosis, M. kansasii, M. avium, M. intracellulare, and M. gordonae. Differential identification of Mycobacterium species has together account for nearly 85% of all mycobacteria recov- traditionally been based upon biochemical reactions (7). The ered in state health laboratories. time required to perform the battery of biochemical tests usually makes traditional taxonomic identification a time- MATERIALS AND METHODS consuming process. More rapid methods of differential iden- tification are needed for the various Mycobacterium species. Microorganisms and growth conditions. Mycobacterium Chemical of cellular fatty acids, especially the isolates were either from the Trudeau Mycobacterial Collec- analysis and high-molecular-weight, a-branched mycolic ac- tion (TMC), formerly at the National Jewish Hospital P-hydroxy or from the ids, has been used as a rapid test in mycobacterial system- Research Center, Denver, Colo., Mycobacteri- atics (10). Extensive studies using two-dimensional thin- ology Laboratory, Centers for Disease Control (CDC), At- were as M. TMC layer chromatography and mass spectrometry with mycolic lanta, Ga., and follows: tuberculosis 102, and 321 and acid methyl esters have revealed a variable species-related 106, 107, 110, 111, 112, 117, 119, 124, 205, 320, distribution of mycobacterial mycolic acid structural types CDC 3900, 3901, 3902, 3903, 3904, 3905, 3906, 3907, 3908 a resistance i.e., isolates (9-13). Recently, a study using thin-layer chromatography and 3909 (from primary drug study, revealed the clinical usefulness of mycolic acid analysis for with no prior exposure to drug therapy); M. kansasii TMC separating Mycobacterium simiae from M. avium-M. intra- 1203, 1204, 1214, and 1217 and CDC 769, 830, 946, 961, 983, were sub- cellulare in a mixed mycobacterial infection (8). 1010, 1069, 1087, 1210, and 1253 (these isolates Other methods of mycolic acid analysis have combined mitted from state health departments to the CDC reference absorption chromatography with high-performance liquid laboratory for study); M. gordonae TMC 1319, 1324, 1325, chromatography (HPLC) and demonstrated the chemical and 1327 and CDC 911, 946, 986, 1196, 1215, 1231, 1245, and uniqueness of the cell wall-bound mycolic acids (15, 18). We 1251 (these isolates were submitted from state health depart- previously used HPLC to separate the different mycolic ments to the CDC reference laboratory for study); M. avium acid-containing genera (1). In this study, we describe a TMC 701, 702, 706, 714, 716, 724, 801, 1461, 1462, 1463, simple, single-step HPLC analysis of the p-bromophenacyl 1464, 1468, 1472, and 1479 and CDC 82-307, 82-905, and esters of mycolic acids extracted from saponified whole cells 82-993; M. intracellulare TMC 1403, 1405, 1406, 1419, 1466, of several species of mycobacteria and demonstrate the 1469, and 1473 and CDC 81-641, 82-421, 82-625, 82-759, distinctly different mycolic acid "fingerprint" patterns pro- 82-1128, 82-1129, and 83-764. All of the CDC isolates were duced by the different species. We examined four strictly or fresh clinical specimens. The pathogenic species included in potentially pathogenic species (M. tuberculosis, M. avium, this study were M. tuberculosis, M. kansasii, M. avium, and M. intracellulare, and M. kansasii) that account for almost M. intracellulare. M. gordonae, a commonly nonpathogenic 90% of the potentially pathogenic mycobacteria and 71% of species, was also included. Isolates were grown on commer- the total (both pathogenic and saprophytic) mycobacteria cially prepared Lowenstein-Jensen slants (Carr-Scarborough recovered in state health laboratories in the United States Microbiologicals, Atlanta, Ga.) at 35°C for 3 weeks before (5). We compared the mycolic acid patterns of both refer- analysis. ence culture strains and clinical isolates to establish standard Identification of mycobacteria. Mycobacteria were identi- species patterns. It was of special interest to determine if the fied by conventional laboratory methods (6, 7). mycolic acid patterns could be used as a rapid identification Mycolic acid extraction and derivatization procedures. My- method for these slowly growing pathogenic mycobacteria. cobacteria were harvested either by washing the Lowen- Although M. gordonae is not pathogenic, it was included in stein-Jensen slants with 2 ml of saponification reagent (25% the study because it represents about 15% of the isolates KOH in 50% ethanol) if growth was scant or by suspending recovered in public health laboratories (5). The five species 1 loopful of cells from Lowenstein-Jensen slants with abun- dant growth in 2 ml of alcoholic KOH. ]3iomass saponifica- tion was performed at 85°C for 18 h in 13-mm glass tubes * Corresponding author. with Teflon-lined screw caps. Saponified cells were cooled to 50 VOL. 26, 1988 IDENTIFICATION OF MYCOBACTERIAL MYCOLIC ACIDS BY HPLC 51 k M. tuberculosis (TMC 102) M. avium (TMC 724) w (n z Oo- (n w k r wcc h w a m 15 20 24 15 20 24 RETENTION TIME (MIN) RETENTION TIME (MIN) M. intracellulare (TMC 1466) w (n M. kansasii (TMC 1214) z O o- h k (n w O Ulc-c w c e 1--w 1 1 h 9D 15 20 24 15 20 24 RETENTION TIME (MIN) RETENTION TIME (MIN) M. gordonae (TMC 1325) w (n 9 z k CLo- (n w Cr: cc O F- w F- w a il1 M 15 20 24 RETENTION TIME (MIN) FIG. 1. High-performance liquid chromatograms of the p-bromophenacyl mycolic acid esters from saponified whole cells of mycobacteria. 52 BUTLER AND KILBURN J. CLIN. MICROBIOL. TABLE 1. Reproductibility of mycolic acid patterns of mycobacteria Species (no. of strains) At (±SEM)a of peak: a b c d e f M. tuberculosis (22) M. kansasii (14) -0.62 (0.006) M. gordonae (12) -0.69 (0.009) M. aviumb (17) -5.07 (0.02) -4.78 (0.02) -4.27 (0.03) -3.75 (0.02) -3.21 (0.01) -0.62 (0.008) M. intracellulareb (14) -5.00 (0.04) -4.69 (0.04) -4.27 (0.04) -3.68 (0.03) -3.18 (0.03) -0.64 (0.008) room temperature and acidified to pH 1 with 6 N HCI. The RESULTS AND DISCUSSION mycolic acids were extracted by adding 2 ml of chloroform, mixing for 20 s on a test tube mixer, and centrifuging to assist The elution patterns of the p-bromophenacyl esters of the separation of the chloroform layer. The extracted mycolic mycolic acids were determined by HPLC for 85 isolates acids were evaporated to dryness and resuspended in chlo- representing five Mycobacterium species (Fig. 1). Each roform for derivatization. The mycolic acids were deriva- analysis was completed in 34 min, from the initial column tized to p-bromophenacyl esters by the method of Durst et equilibration to the end of the program run. The mycolic acid al. (4). Briefly, a mixture containing the extracted mycolic esters of these mycobacteria eluted between 15 and 23 min. acids in 0.5 ml of chloroform-2 mg of potassium car- The p-bromophenacyl esters of "standard," purified my- bonate-25 ,ul ofp-bromophenacyl bromide in acetonitrile-25 colic acids from M. tuberculosis and M. smegmatis corre- pul of the catalyst dicyclohexyl-18-crown-6 ether in acetoni- sponded directly in retention times and overall patterns to trile was heated for 45 min at 85°C in Teflon-capped 5-ml the derivatized mycolic acids that we obtained from whole Reacti-Vials (Pierce Chemical Co., Rockford, Ill.) with organisms, and these standards were used as a presumptive constant stirring with Teflon-coated magnetic stirrers. The identification of the mycolic acids. We found that the deri- reagents were included a kit obtained from Alltech Associ- vatized products were stable for months at an ambient ates, Inc., Applied Science Div., State College, Pa. Chloro- temperature. Components of Lowenstein-Jensen medium, form was used instead of the acetonitrile recommended for excess derivatization reagents, acetonitrile (from the reagent shorter-chain fatty acid derivatization because the long- kit), and short-chain cellular fatty acids (C18 or less) all chain, high-molecular-weight mycolic acids were more sol- eluted within 5 min and did not interfere with the identifica- uble in chloroform. After derivatization, the p-bromophe- tion of the mycolic acids. Quantitation of the method by use nacyl esters of the mycolic acids were filtered through of an M. kansasii culture revealed that definitive mycolic 0.45-,um-pore nylon 66 membrane filters, evaporated to acid fingerprint patterns could be achieved with as few as 2.5 dryness, and resuspended in 100 pil of chloroform for anal- x 106 CFU. ysis. M. tuberculosis had the least complicated mycolic acid HPLC conditions. HPLC of the p-bromophenacyl esters of pattern, with a cluster of seven peaks that eluted between 21 the mycolic acids was done with an HPLC model 450 data and 23 min and one major, central peak (designated k). M. system controller (Beckman Instruments, Inc., Fullerton, kansasii and M.